Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 459
Immune Disorders Drugs 196
Cardiovascular Drugs 161
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 112
Clinical Trials 107
Central Nervous System Drugs 105
Musculoskeletal Disorders Drugs 97
Pharmaceuticals 95
Leukemia Drugs 82
Hematological Drugs 80
Liver and Kidney Disorders Drugs 76
Lymphoma Drugs 62
Dermatological Drugs 59
Diabetes Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Drug Delivery 36
Pharmaceutical Intermediates 35
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
HIV/AIDS Drugs 19
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Vaccines 8
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Pharmacoeconomics 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



279 reviews

2,422 Results (Page 12 of 122)
- Relevance
  Sort by

Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
359 Pages
Global

From

€2235EUR$2,500USD£1,944GBP

Antimicrobial Therapeutics - Global Strategic Business Report

 Report
August 2025
494 Pages
Global

From

€5230EUR$5,850USD£4,550GBP

Cephalosporin Drugs - Global Strategic Business Report

 Report
August 2025
398 Pages
Global

From

€5230EUR$5,850USD£4,550GBP

Organ Transplant Immunosuppressant Drugs - Global Strategic Business Report

 Report
August 2025
196 Pages
Global

From

€5230EUR$5,850USD£4,550GBP

Non-muscle Invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
345 Pages
Global

€4465EUR$4,995USD£3,885GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Muscle-invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
321 Pages
Global

€4465EUR$4,995USD£3,885GBP

Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2025

 Report
April 2025
450 Pages
Global

From

€3571EUR$3,995USD£3,107GBP

Anxiety Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

 Report
November 2023
190 Pages
Global

From

€4023EUR$4,500USD£3,500GBP

Hepatitis C Treatment Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

 Report
February 2022
87 Pages
Global

From

€3200EUR$3,834USD£2,881GBP

Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
322 Pages
Global

From

€2235EUR$2,500USD£1,944GBP

Brain Tumor Drugs Market Analysis & Forecast 2024-2034: Market; By Therapy; By Indication; By Distribution Channel; and By Region

 Report
October 2023
145 Pages
Global

From

€2816EUR$3,150USD£2,450GBP

Muscle Invasive Bladder Cancer- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1341EUR$1,500USD£1,167GBP

United States Pre-Exposure Prophylaxis (PrEP) Market, Competition, Forecast and Opportunities, 2018-2028

 Report
October 2023
78 Pages
United States

From

€3129EUR$3,500USD£2,722GBP

Brain Tumor Drugs Market Report 2025

 Report
March 2025
175 Pages
Global

From

€4014EUR$4,490USD£3,492GBP

Bladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
November 2022
1018 Pages
Global

From

€2235EUR$2,500USD£1,944GBP

Liver Cancer Drug Market Size, Share & Trends Analysis Report by Therapy (Targeted Therapy, Immunotherapy, Chemotherapy), Type (Hepatocellular Carcinoma), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), Region, and Segment Forecasts 2025-2030

 Report
February 2025
100 Pages
Global

From

€5319EUR$5,950USD£4,628GBP

Liver Cancer Drugs - Global Strategic Business Report

 Report
August 2025
277 Pages
Global

From

€5230EUR$5,850USD£4,550GBP

Schizophrenia Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4014EUR$4,490USD£3,492GBP

Immunosuppressants - Global Strategic Business Report

 Report
August 2025
349 Pages
Global

From

€5230EUR$5,850USD£4,550GBP

Liver Diseases Therapeutics Market by Disease Type, Therapy Type, Drug Class, Route of Administration, Distribution Channel, End User - Global Forecast to 2030

 Report
May 2025
191 Pages
Global

From

€3169EUR$3,545USD£2,757GBP

€3521EUR$3,939USD£3,064GBP

2,422 Results (Page 12 of 122)
- 1
- 10
- 11
- 12
- 13
- 14

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.